| Product Name | Enlimomab |
|---|---|
| CAS | 142864-19-5 |
| Storage condition | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 1 mg | 3-5days | ¥5200.00 | Visible after login | |
| 5 mg | 3-5days | ¥22100.00 | Visible after login | |
| 10 mg | 3-5days | ¥38000.00 | Visible after login | |
| 50 mg | 3-5days | ¥152000.00 | Visible after login | |
| 100 mg | 3-5days | ¥275000.00 | Visible after login |
| Product Name | Enlimomab |
|---|---|
| CAS | 142864-19-5 |
| Storage condition | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody to the human ICAM-1, inhibits leukocyte adhesion to the vascular endothelium, thereby decreasing leukocyte extravasation and inflammatory tissue injury. Enlimomab has anti-inflammatory effects, and can be used for stroke research .